Abstract
Chunyan Luo
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Comparative efficacy and safety of nitazoxanide-based triple therapy versus standard triple therapy in treating Helicobacter pylori infections: an updated systematic review and meta-analysis of randomized controlled trials
10.1097/mcg.0000000000002328 · 2026
Global primary antibiotic resistance rate of Helicobacter pylori in recent 10 years: a systematic review and meta-analysis
10.1111/hel.13103 · 2024
Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis
10.1016/s2468-1253(23)00281-9 · 2024
Treatment failure is a key factor in the development of Helicobacter pylori resistance
10.1111/hel.13091 · 2024
Helicobacter pylori infection in children versus adults, differences in management guidelines: risks and benefits of treatment in childhood
10.1111/hel.70063 · 2025
No additional external references are available.